Hong Kong Beverage Stock News

Trying to decide whether to buy, hold, or sell CK Hutchison Holdings? You are not alone. Lately, this stock has been on a steady climb, and every investor watching it is wondering whether now is the right moment to act or to wait it out. Over the past week, shares are up 1.5%, and if you zoom out, you will see a tidy 2.9% rise over the last month. The real eye-opener is the longer-term picture, with shares up 24.6% year-to-date and a remarkable 28.5% for the year. Looking all the way back...

Bank of Chongqing (SEHK:1963) delivered a 7.6% gain in earnings over the last year, which outpaced its 5-year average annual growth rate of 4.2%. Net profit margins came in at 48.9%, a slight dip from the previous year’s 50.4%, but the company still maintains a reputation for high quality past earnings. With steady earnings growth, investors will be weighing this track record and positive valuation metrics against some caution on future dividend sustainability. See our full analysis for Bank...

ZhongAn Online P & C Insurance Co., Ltd. announced that its gross written premiums from January 1 to September 30, 2025 totaled approximately RMB 26.93 billion. This release gives investors a clearer view of the company's top-line insurance revenue, a critical measure for the underwriting segment within the insurtech space. We will explore how this sales update on gross written premiums could influence the company’s investment narrative and future prospects. These 15 companies survived and...

CTF Services (SEHK:659) is forecasting earnings growth of 13.78% per year and revenue growth of 4.2% per year, according to its latest filings. Net profit margins have climbed to 8.9%, up from last year’s 8.3%, with recent results given a boost by a one-off gain of HK$2.4 billion in the twelve months ending June 30, 2025. Over the past five years, earnings have grown at 27.4% annually, and the current price-to-earnings ratio of 15.8x appears attractive compared to the peer group average of...

As of October 2025, Asian markets have shown resilience, with significant gains in technology-focused shares and an overall positive sentiment despite some economic challenges. For investors looking to explore opportunities beyond the major indices, penny stocks remain a compelling area of interest. Although the term "penny stocks" may seem outdated, it continues to represent smaller or newer companies that can offer unique growth potential when backed by strong financials and strategic...

Envision Greenwise Holdings Limited recently filed a follow-on equity offering to raise HK$155 million through the sale of 50,000,000 ordinary shares at HK$3.1 each. This direct listing signals the company's intent to secure additional funding, which may influence its capital structure and future initiatives. We'll explore how this capital-raising move shapes Envision Greenwise Holdings' investment narrative, particularly regarding its potential impact on shareholder dilution. AI is about to...

China Galaxy Securities Co., Ltd. announced it will propose amendments to its Articles of Association at its upcoming extraordinary general meeting, responding to major updates in China’s Company Law and sweeping regulatory reforms affecting corporate governance. This move reflects an effort to enhance operational transparency and modernize governance as regulatory frameworks evolve across China’s securities sector. We'll explore how these proposed governance changes could shape China Galaxy...

Aluminum Corporation of China (SEHK:2600) has announced a joint venture with Chinalco, Yunnan Copper, Chihong Zinc & Germanium, and Chinalco Capital. This move is classified as a connected transaction under Hong Kong Listing Rules, so it requires public disclosure but does not affect company control or financial consolidation. See our latest analysis for Aluminum Corporation of China. Investor sentiment around Aluminum Corporation of China has been on an upswing, with the recent joint venture...

Comba Telecom Systems Holdings recently announced that Ms. Wong Lok Lam resigned from her roles on the board and key committees, with Dr. Tan Khee Giap appointed as the new independent non-executive director and committee chairman effective 16 October 2025. Dr. Tan's extensive board experience throughout Asia and his advisory roles across major listed organizations highlight the company's focus on deepening governance and regional insights. We'll explore how bringing Dr. Tan’s governance...

Alphamab Oncology (SEHK:9966) shares pulled back after recent trading, with the stock dipping nearly 2% in the latest session. Investors are weighing ongoing shifts in the biotech space and considering how company fundamentals stack up right now. See our latest analysis for Alphamab Oncology. After a remarkable rally earlier this year, Alphamab Oncology’s share price cooled off, slipping 17.7% over the past week even as its year-to-date gain still stands out at over 245%. While momentum has...

361 Degrees International announced on October 13, 2025, that third quarter sales for both its core and kids branded products grew approximately 10% year-over-year through offline channels, while the company's e-commerce platform saw retail sales increase by about 20% compared to the same period in 2024. This broad-based sales growth across physical and digital channels underscores the company's ability to strengthen its market position among both traditional and online consumers. We’ll now...

Prada (SEHK:1913) reported its nine-month 2025 sales, surpassing 4 billion euros and continuing a streak of growth for the nineteenth consecutive quarter. Miu Miu’s retail sales soared and offset softer performance from the flagship Prada brand. See our latest analysis for Prada. Prada’s latest nine-month sales update gave its shares a strong push, with a 6.44% jump in the latest trading session and a 5.12% gain over the past week. While year-to-date share price returns are still down over...

AAC Technologies Holdings (SEHK:2018) just kicked off a substantial share buyback program authorized by its shareholders. The company aims to repurchase up to 10% of its issued share capital, with the move intended to boost value for existing investors. See our latest analysis for AAC Technologies Holdings. Over the past year, AAC Technologies Holdings has not only launched this major buyback, but momentum has also been building. While the share price has been volatile in recent months, the...

On October 20, 2025, CNOOC Limited announced that Mr. Zhou Xinhuai resigned as Chief Executive Officer, Executive Director, and Vice Chairman of the Board, also stepping down from the Strategy and Sustainability Committee on the same day. This leadership transition marks a significant shift for the company, as executive changes at this level can influence both strategic direction and investor sentiment. We'll examine how the CEO's departure could alter CNOOC's long-term priorities and risk...

Innovent Biologics (SEHK:1801) shares have shown modest movement over the past week, following recent shifts in sentiment across the broader biotech market. Investors are considering the company’s overall performance dynamics and how they compare to sector peers. See our latest analysis for Innovent Biologics. Innovent Biologics’ share price has soared 140.99% year-to-date, signaling strong momentum after a sustained rally. The latest uptick is likely fueled by renewed optimism over the...

Yankuang Energy Group Company Limited announced that in the third quarter and first nine months of 2025, it achieved increased saleable coal production volumes, reporting 4,603 ten kiloton and 13,589 ten kiloton respectively, up from the prior year. This rise in output highlights the company's capacity for operational growth and efficiency at a time when energy sector performance is under close investor focus. We'll examine how these increased production figures reinforce Yankuang Energy...

Earlier this month, RemeGen announced positive Phase III clinical trial results for disitamab vedotin plus toripalimab in HER2-expressing urothelial carcinoma at the ESMO Congress and for telitacicept in primary Sjögren’s disease at ACR, both showing significant clinical benefits and improved safety profiles compared to standard treatments. The disitamab vedotin trial is the first Chinese-led urological oncology research presented at ESMO's prestigious Presidential Symposium and published in...

Nexteer Automotive recently held the opening ceremony for its new Mexico Technical Center (MXTC), highlighting an expansion of local engineering and technical support capabilities for OEM customers in Mexico and North America. This center emphasizes the company’s focus on innovation, regional collaboration, and enhancing operational efficiency to support customer-focused growth through a skilled, multidisciplinary workforce. We'll explore how the enhanced engineering capabilities brought by...

China Nonferrous Mining Corporation Limited recently reported a 12% year-on-year increase in copper cathode production and a 13% rise in profit, driven by higher copper prices and output. Despite significant declines in liquid sulphur dioxide and cobalt production, the company's improved core copper operations have been a key driver for its financial performance. We'll explore how the robust copper production figures shape China Nonferrous Mining's investment narrative going forward. These...

Robosense Technology (SEHK:2498) made headlines at the International Conference on Intelligent Robots and Systems (IROS 2025) by unveiling its AC2 "Robot Manipulation Eye," a next-generation sensor with advanced perception capabilities and an industrial focus. See our latest analysis for Robosense Technology. Following the AC2 launch and industry buzz, Robosense Technology has seen notable momentum build in its stock. The company’s year-to-date share price return stands at 21.92%, while the...

Giant Biogene Holding Co., Ltd recently announced that its subsidiary received approval from the China National Medical Products Administration for a new collagen-based dermal filler designed to address facial dynamic wrinkles. This approval underscores the company’s ongoing investment in skin rejuvenation technologies and further expands its offerings in the health and beauty industry. We'll explore how this regulatory milestone, especially the focus on leveraging existing brands and...

Sun Hung Kai Properties (SEHK:16) traded higher as market sentiment picked up on hopes of easing geopolitical tensions, following reports of a possible US-China leaders' meeting. Investors appear to be responsive to changes in global risk perception. See our latest analysis for Sun Hung Kai Properties. Sun Hung Kai Properties has enjoyed a solid run lately, with market optimism fueling a 1-day share price return of 1.66% and a robust year-to-date gain of nearly 29%. While momentum has picked...

Great Wall Motor (SEHK:2333) reported earnings growth of 14.9% per year over the past five years, with forecasts projecting EPS growth of 12.2% annually and revenue growth of 10.4% per year ahead. The company’s current net profit margin sits at 5.1%, slightly below last year’s 6.3%, as the latest twelve months’ results include a notable one-off gain of CN¥3.0 billion. With revenue forecasted to outpace the broader Hong Kong market and shares trading at HK$15.47, below their estimated fair...

CStone Pharmaceuticals (SEHK:2616) is gaining attention after two key developments: a positive opinion from Europe’s drug regulator for sugemalimab in lung cancer, and fresh data on its early-stage immunotherapy candidates. Investors are watching closely. See our latest analysis for CStone Pharmaceuticals. The recent surge in CStone Pharmaceuticals’ share price, up nearly 158% year-to-date, reflects growing investor confidence on the back of regulatory wins and progress with its immunotherapy...